Bowel Movement Health in 2026
Bowel movement health has quietly moved from a taboo subject into the mainstream of preventive wellness conversations — and the data backing this shift is hard to ignore. In 2026, a nationally representative survey of 1,249 American adults conducted by YouGov on behalf of Sunsweet Growers found that 95% of U.S. adults rate good digestion as important to their overall well-being — placing it on par with hydration (97%) and vitamin intake (92%). That number alone tells you how dramatically the conversation has changed. People are no longer content to shrug off irregular patterns, unexplained bloating, or shifts in stool consistency. They want answers, and increasingly, they are turning to clinical tools like the Bristol Stool Form Scale (BSFS), gut tracking apps, and their own food diaries to find them.
What makes this moment particularly significant is the convergence of consumer awareness and hard clinical evidence. Peer-reviewed research — including a landmark study from the Institute for Systems Biology (ISB) published in Cell Reports Medicine and a growing body of large-scale NHANES data — now confirms that how often and how well you have a bowel movement is a genuine proxy for broader systemic health. From colorectal cancer screening triggers to gut microbiome modulation, bowel movement frequency and consistency are no longer just gastroenterology metrics. They are everyday wellness signals. This article brings together the most current and verified bowel movement health statistics for 2026, pulling from peer-reviewed research, national health surveys, clinical guidelines, and the latest consumer health data.
Interesting Bowel Movement Facts 2026
Before diving into the statistics, here are some of the most surprising and medically significant facts about bowel movement health drawn from current research and clinical sources.
| Fact | Detail |
|---|---|
| Normal BM range | 3 times per day to 3 times per week — both are medically considered normal for healthy adults |
| “Goldilocks zone” | The healthiest individuals in an ISB study of 1,425 adults reported going once or twice a day |
| Most common frequency | Almost half of Americans report having exactly one bowel movement per day |
| Bristol Scale average (healthy adults) | Healthy volunteers averaged a BSFS score of 3.7 (near-ideal) vs IBS-D patients who averaged 5.0 |
| Stool water content | Normal stool is approximately 75% water — dehydration directly hardens stool |
| Transit time signal | Type 1 and 2 stools on the Bristol Scale indicate slow colonic transit; Types 6 and 7 indicate accelerated transit |
| Top stool type globally | Type 3 (35.6%) and Type 4 (32.5%) are the most commonly reported stool types in healthy populations |
| Fiber gap, 2026 | 90% of women and 97% of men in the U.S. do not meet their daily fiber requirements |
| Average U.S. fiber intake | Americans consume on average only 17 g/day — roughly half the recommended adequate intake level |
| Constipation prevalence | 9%–20% of U.S. adults meet criteria for chronic idiopathic constipation (CIC) |
| Global constipation rate | Estimated global prevalence of chronic constipation is 11.7% using Rome IV criteria (World Gastroenterology Organisation, 2025) |
| Gender difference | Chronic constipation is twice as common in women as in men globally |
| Older adults | Constipation prevalence reaches up to 32% in older adults in some regions |
| IBS global rate | ~4.1% of the global population meets Rome IV criteria for IBS (Rome Foundation Global Study) |
| Ideal passing time | A healthy bowel movement should take 10–15 minutes to pass; longer may signal constipation or hemorrhoids |
| ISB mortality link | Stool frequency of fewer than 7 times/week is associated with significantly higher all-cause mortality risk in NHANES data |
| Gut health app market 2025 | The digital health tracking apps market was valued at USD 28.46 billion in 2025, growing at a 17.3% CAGR |
Sources: Institute for Systems Biology (ISB) / Cell Reports Medicine, 2024; NHANES data (PubMed/PMC); YouGov / Sunsweet Nutrition and Digestive Health Survey, Dec 2025; World Gastroenterology Organisation Guidelines, 2025; Rome Foundation Global Study (Gastroenterology, 2021); Research and Markets, 2025; NCBI StatPearls, Dec 2025
These facts frame something important: bowel movement health is not a niche clinical concern — it is one of the most accessible, real-time windows into your overall physiology. The sheer breadth of these data points, from microbiome associations to mortality risk, makes this one of the more underappreciated areas of preventive medicine. What is equally striking is the dietary disconnect — nearly all American adults are chronically under-fueling the gut with fiber, and the downstream effects on stool regularity, microbiome composition, and long-term disease risk are well-documented and growing harder to dismiss. The conversation in 2026 has moved decisively from “is this worth tracking?” to “how do we track it better?”
Bristol Stool Form Scale (BSFS) Type Distribution 2026 | What Your Stool Type Says
The Bristol Stool Form Scale, developed by Dr. Ken Heaton and Dr. Stephen Lewis at the University of Bristol and first published in 1997, remains the gold-standard clinical tool for classifying stool consistency. Its seven-type system is now used worldwide in both clinical practice and consumer gut health apps.
BSFS TYPE DISTRIBUTION IN HEALTHY POPULATIONS (%)
(Based on cross-sectional studies, NHANES, and South Indian cohort data)
Type 1 (Separate hard lumps) ██░░░░░░░░░░░░░░░░░░ ~8% ← CONSTIPATION
Type 2 (Lumpy sausage) ████░░░░░░░░░░░░░░░░ ~12% ← CONSTIPATION
Type 3 (Cracked sausage) ████████████████░░░░ ~36% ← IDEAL
Type 4 (Smooth sausage) █████████████░░░░░░░ ~33% ← IDEAL (perfect poop)
Type 5 (Soft blobs) ██░░░░░░░░░░░░░░░░░░ ~7% ← TRENDING DIARRHEA
Type 6 (Mushy) █░░░░░░░░░░░░░░░░░░░ ~3% ← DIARRHEA
Type 7 (Liquid) █░░░░░░░░░░░░░░░░░░░ ~2% ← DIARRHEA
ZONE KEY: Types 1-2 = Constipation | Types 3-4 = Ideal | Types 5-7 = Diarrhea
| Bristol Stool Type | Description | Health Indication | Approx. Prevalence in Healthy Adults | Recommended Action |
|---|---|---|---|---|
| Type 1 | Separate hard lumps, like nuts | Constipation — very slow transit | ~8% | Increase fiber and water |
| Type 2 | Sausage-shaped but lumpy | Constipation — slow transit | ~12% | Increase fiber and water |
| Type 3 | Like a sausage with cracks | Ideal — normal transit | ~36% | Maintain current diet |
| Type 4 | Smooth, soft sausage or snake | Ideal — perfect transit | ~33% | Maintain current diet |
| Type 5 | Soft blobs with clear edges | Trending toward diarrhea | ~7% | Increase soluble fiber |
| Type 6 | Fluffy, mushy, ragged edges | Mild diarrhea | ~3% | Review diet, hydration |
| Type 7 | Entirely liquid, no solids | Diarrhea | ~2% | Seek medical advice if prolonged |
Sources: Bristol Stool Form Scale original research (Lewis & Heaton, 1997, Scandinavian Journal of Gastroenterology); Validity and Reliability of BSFS (Blake et al., 2016, PubMed); Cross-sectional study, South Indian population (PMC, 2019); Stanford Medicine Pediatric Surgery (2026); Bladder & Bowel Community (2026)
The Bristol Stool Form Scale is far more than a clinical curiosity — it is a validated, reliable diagnostic lens used across gastroenterology, pediatrics, nursing, and increasingly, consumer health technology. Research published in peer-reviewed journals confirms that Types 3 and 4 remain the ideal targets, with stool water content correlating directly with transit time. In one key validity study, healthy adults averaged a BSFS score of 3.7, while patients with diarrhea-predominant IBS (IBS-D) averaged 5.0 — a statistically significant difference (p < 0.001). What this table also highlights is that the vast majority of adults in healthy populations cluster around Types 3 and 4, which together account for roughly 68% of reported stool types. The outlier categories at both ends — Types 1–2 and 6–7 — collectively account for only about a quarter of healthy individuals, yet they represent the most clinically actionable signals. If you or your patients are consistently outside the Type 3–4 window, that pattern — not an isolated episode — is the trigger for dietary or medical review.
Bowel Movement Frequency Statistics 2026 | How Often Should You Go?
One of the most persistent myths in gut health is the idea that everyone should have exactly one bowel movement per day. The clinical reality, confirmed repeatedly by large-scale population data, is far more nuanced.
BOWEL MOVEMENT FREQUENCY — U.S. ADULT DISTRIBUTION (%)
(Based on Healthline/American Gut Check survey of 2,000+ Americans)
3× per day ██░░░░░░░░░░░░░░░░░░ ~5% ← NORMAL HIGH
2× per day ████░░░░░░░░░░░░░░░░ ~15% ← NORMAL HIGH
1× per day ████████████████████ ~48% ← MOST COMMON
3-6×/week ████████░░░░░░░░░░░░ ~22% ← NORMAL LOW
1-2×/week ████░░░░░░░░░░░░░░░░ ~10% ← CONSTIPATION ZONE
Medically accepted normal range: 3/day ←——————————→ 3/week
ISB "Goldilocks zone": Once or twice daily
| Frequency Category | Bowel Movements | ISB Classification | Health Implication | % of U.S. Adults (est.) |
|---|---|---|---|---|
| High-normal | 1–3 times per day | High-normal | Associated with optimal microbiome markers | ~20% |
| Most common | Once per day | Low-normal to high-normal | Broadly healthy; consistent pattern is key | ~48% |
| Low-normal | 3–6 times per week | Low-normal | Generally healthy; monitor for changes | ~22% |
| Constipation threshold | 1–2 times per week | Constipation | Associated with gut dysbiosis, microbial toxin accumulation | ~10% |
| Diarrhea range | More than 3 per day | Diarrhea (if loose) | Associated with gut inflammation or accelerated transit | ~5% (chronic) |
Sources: Institute for Systems Biology (ISB), Cell Reports Medicine, July 2024; Healthline / American Gut Check (2,000+ U.S. adults survey); ScienceInsights, March 2026; HealthCentral (medically reviewed by Dr. David Padua, M.D., April 2026); NHANES BSFS study (PubMed, PMID 28762379)
The headline finding from the ISB’s study of 1,425 healthy adults is one of the most striking in recent gut health research: the “Goldilocks zone” of bowel movement frequency is once or twice a day, and deviation in either direction — too frequent or too infrequent — was associated with measurable physiological differences including alterations in gut microbiome composition and blood metabolite profiles. What is equally important is the NHANES large-scale data showing that stool frequency of fewer than 7 times per week is a statistically significant risk factor for all-cause mortality. That finding — while likely mediated by confounding lifestyle factors — underscores the value of treating bowel regularity as a serious health metric rather than a trivial lifestyle variable. The practical takeaway is straightforward: any noticeable, sustained shift from your personal baseline frequency, even if it stays within the “normal” 3-to-3 range, warrants tracking and potentially a conversation with a healthcare provider.
Constipation & Diarrhea Prevalence Statistics 2026 | Digestive Disorder Burden
Functional gastrointestinal disorders — including chronic constipation, IBS, and functional diarrhea — collectively affect a staggering proportion of the global adult population. The most up-to-date figures from the World Gastroenterology Organisation and the Rome Foundation paint a detailed picture.
GLOBAL & U.S. DIGESTIVE DISORDER PREVALENCE (%)
(Rome IV Criteria | Rome Foundation Global Study + WGO Guidelines 2025)
Functional Constipation (Global) ████████████░░░░░░░░ 11.7%
Chronic Constipation (U.S. adults) ████████████████░░░░ 9–20%
Functional Dyspepsia (Global) ██████░░░░░░░░░░░░░░ 7.2%
Proctalgia Fugax (Global) █████░░░░░░░░░░░░░░░ 5.9%
IBS — U.S. Rate █████░░░░░░░░░░░░░░░ 5.3%
Functional Diarrhea (Global) ████░░░░░░░░░░░░░░░░ 4.7%
IBS (Global Rome IV) ████░░░░░░░░░░░░░░░░ 4.1%
IBS in Women (global, Rome III) ████████████░░░░░░░░ ~12%
IBS in Men (global, Rome III) ████████░░░░░░░░░░░░ ~9%
Constipation — older adults ████████████████████ up to 32%
| Condition | Population | Prevalence | Key Risk Factor | Gender Skew |
|---|---|---|---|---|
| Chronic Idiopathic Constipation (CIC) | U.S. adults | 9%–20% | Low fiber, sedentary lifestyle, medications | 2× more common in women |
| Global Functional Constipation (Rome IV) | Global | 11.7% | Diet, geography, age | Female predominance |
| Constipation in older adults | 65+ globally | Up to 32% | Reduced mobility, polypharmacy | Female predominance |
| IBS — Rome IV (Global) | Global | 4.1% | Gut dysbiosis, stress, post-infection | Female-to-male OR: 1.8 |
| IBS — Rome III (Global, higher estimate) | Global | ~10% | Post-infectious, dietary triggers | Female predominance |
| IBS — United States | U.S. adults | 5.3% | Dietary patterns, stress | Higher in women |
| Functional Diarrhea (Global) | Global | 4.7% | Accelerated transit, microbiome shifts | Slight male skew |
| Any Functional GI Disorder (FGIDs) | Global (female) | 49% | Multifactorial | Predominantly female |
| Any Functional GI Disorder (FGIDs) | Global (male) | 36.6% | Multifactorial | — |
Sources: World Gastroenterology Organisation (WGO) Constipation Guidelines, 2025; Rome Foundation Global Study, Gastroenterology (Sperber et al., 2021); American Journal of Gastroenterology (Oh et al., 2020); NCBI PMC — Epidemiology and Burden of Chronic Constipation; ISB / Cell Reports Medicine, 2024
These numbers reveal just how significant the global digestive disorder burden truly is. When the Rome Foundation’s Global Study reports that 49% of women and 36.6% of men worldwide meet criteria for at least one functional gastrointestinal disorder, it reframes the entire conversation — these are not edge-case conditions but near-majority experiences for the global adult population. The U.S.-specific chronic constipation data is equally telling: somewhere between 9% and 20% of American adults — potentially 30 to 65 million people — meet clinical criteria for CIC, yet fewer than 38% of those with constipation symptoms ever discuss it with a clinician (American Journal of Gastroenterology). The under-reporting and under-treatment gap is enormous. For older adults, the situation is even more pronounced, with constipation prevalence reaching up to 32% in some regions, driven by reduced mobility, polypharmacy, and dietary changes that accompany aging.
Fiber Intake & Gut Health Statistics 2026 | The Dietary Root of Bowel Regularity
Dietary fiber is the single most modifiable driver of bowel movement regularity, stool consistency, and gut microbiome health. The statistics on fiber consumption in 2026 remain deeply concerning — and the gap between what is recommended and what is actually eaten has not closed.
U.S. FIBER INTAKE GAP 2026
(NCBI StatPearls, Dec 2025 | YouGov / Sunsweet Survey, Dec 2025 | Dietary Guidelines for Americans 2020-2025)
Recommended intake (women): ████████████████████ 25–28 g/day
Recommended intake (men): ████████████████████ 28–34 g/day
Average U.S. adult intake: ██████████░░░░░░░░░░ ~17 g/day
% women meeting target: ██░░░░░░░░░░░░░░░░░░ ~10%
% men meeting target: █░░░░░░░░░░░░░░░░░░░ ~3%
% children/adults failing: ████████████████████ ~94%
Gap vs recommendation: Approx. 50% shortfall for average adult
| Metric | Value | Benchmark / Guideline | Source |
|---|---|---|---|
| Recommended daily fiber — Women | 25–28 g/day | Dietary Guidelines for Americans 2020–2025 | USDA / DHHS |
| Recommended daily fiber — Men | 28–34 g/day | Dietary Guidelines for Americans 2020–2025 | USDA / DHHS |
| Average U.S. adult fiber intake (2017–2020) | ~17 g/day | ~50% of adequate intake | NCBI StatPearls, Dec 2025 |
| % women meeting daily fiber target | ~10% | Target: 100% | Dietary Guidelines for Americans |
| % men meeting daily fiber target | ~3% | Target: 100% | Dietary Guidelines for Americans |
| % of all U.S. adults/children failing to meet AI | ~94% | Target: <50% failing | NCBI StatPearls, Dec 2025 |
| U.S. adults who say good digestion is important | 95% | — | YouGov / Sunsweet Survey, Dec 2025 |
| U.S. adults who believe gut health affects daily wellbeing | 84% | — | YouGov / Sunsweet Survey, Dec 2025 |
| U.S. daily fiber gap (population-level) | ~16 g/day shortfall | — | NCBI / Dietary Guidelines estimate |
| Economic opportunity from fiber gap | ~$2 billion kg/year | For food/supplement industry | NCBI / medrxiv, 2026 |
Sources: NCBI StatPearls — Role of Dietary Fiber in Health Promotion (updated December 1, 2025); YouGov / Sunsweet Nutrition and Digestive Health Survey (1,249 U.S. adults, December 18–19, 2025); Dietary Guidelines for Americans 2020–2025 (USDA/DHHS); PMC — Dietary Fiber and the Dietary Guidelines for Americans (2021); medrxiv / Short-Chain Oat Fiber study, January 2026
The disconnect between public awareness and actual dietary behavior is one of the defining patterns in the 2026 gut health landscape. A survey of 1,249 representative American adults (YouGov, December 2025) found that 95% consider good digestion important — yet the same population collectively consumes only about half the recommended daily fiber, and fewer than 10% of women and 3% of men are actually hitting their targets (NCBI StatPearls, December 2025). This is not simply a knowledge gap; it reflects systemic issues with food environment, dietary pattern trends (including the rise of low-carb and carnivore diets that restrict fiber-rich plants), and confusion about what foods actually deliver meaningful fiber amounts. From a bowel movement health perspective, this fiber deficit is directly visible in stool consistency data — hard, difficult-to-pass stools (Types 1–2 on the Bristol Scale) are strongly linked to inadequate fiber and water intake. Increasing both simultaneously — not fiber alone — is what the evidence supports for improving transit time and stool form.
Stool Color Health Guide 2026 | What Normal and Abnormal Colors Mean
Stool color is one of the fastest-changing and most diagnostically informative characteristics of a bowel movement. While color variation is often dietary, certain shades serve as clinical red flags that should prompt prompt medical evaluation.
STOOL COLOR HEALTH SIGNAL CHART 2026
(Cleveland Clinic / HealthPartners / MedicalNewsToday — Clinically Reviewed Sources)
BROWN (medium to dark) ████████████████████ NORMAL — bile breakdown products
GREEN ███░░░░░░░░░░░░░░░░░ Usually dietary — rapid transit or leafy greens
YELLOW / GREASY ██░░░░░░░░░░░░░░░░░░ Possible malabsorption — check fat content
PALE / CLAY / WHITE █░░░░░░░░░░░░░░░░░░░ ALERT — possible bile duct/liver issue
ORANGE █░░░░░░░░░░░░░░░░░░░ Often beta-carotene; rule out bile acid diarrhea
BLACK / TARRY ██░░░░░░░░░░░░░░░░░░ ALERT — possible upper GI bleed; or iron/Pepto-Bismol
RED (bright) ██░░░░░░░░░░░░░░░░░░ ALERT — lower GI bleed or hemorrhoids vs. dietary (beets)
| Stool Color | Most Common Cause | Potential Medical Concern | Action Recommended |
|---|---|---|---|
| Medium to Dark Brown | Normal bile breakdown (bilirubin + bile) | None | Maintain healthy diet |
| Green | Leafy greens, iron supplements, rapid gut transit | Infection or diarrhea if persistent | Monitor; see doctor if ongoing |
| Yellow / Greasy / Floating | High fat foods, malabsorption | Celiac disease, pancreatic insufficiency | Seek evaluation if persistent |
| Pale / Clay / White | Lack of bile flow | Liver disease, bile duct obstruction, hepatitis | See a doctor promptly |
| Orange | High beta-carotene foods (carrots, yams) | Bile acid diarrhea, gallbladder dysfunction | See doctor if >2–3 days |
| Black / Tarry | Iron supplements, bismuth (Pepto-Bismol) | Upper GI bleeding (esophagus, stomach) | Seek urgent care if unexplained |
| Bright Red | Beets, red dye foods, hemorrhoids | Lower GI bleeding, rectal cancer | See a doctor if unexplained |
| Greenish-Brown | Normal variation | None in most cases | No action needed |
Sources: Cleveland Clinic — Stool Poop Color (December 2025); HealthPartners — Healthy Poop Chart (December 2025); Medical News Today — Types of Poop (reviewed 2024); WebMD — Bristol Stool Chart, reviewed 2025; New York Gastroenterology Associates (NYGA), 2025
Stool color is a passive, zero-effort diagnostic tool available to every person every day — yet it remains one of the least utilized early-warning systems in personal health monitoring. The core principle is simple: any shade of brown is normal, including greenish-brown, as it reflects the natural chemical transformation of bile (bilirubin) as it passes through the digestive tract. The concern arises when colors move to the extremes — particularly black tarry stools, bright red stools, or pale/clay-colored stools — all of which can signal conditions ranging from hemorrhoids and dietary causes to serious upper or lower gastrointestinal bleeding, liver disease, or bile duct obstruction. Clinicians consistently emphasize that a single off-color episode after eating beets, spinach, or taking iron supplements is not alarming. The signal to pay attention to is persistently abnormal color lasting more than two to three days in the absence of a clear dietary cause. That pattern, combined with symptoms like pain, fatigue, or unexplained weight loss, should always prompt prompt medical evaluation.
Bowel Movement Tracking & Digital Gut Health Market Statistics 2026
The intersection of gut health awareness and digital health technology has created a fast-growing market for bowel movement tracking tools. Clinicians increasingly recommend structured tracking for patients managing IBS, IBD, Crohn’s disease, and chronic constipation.
DIGITAL HEALTH TRACKING APPS MARKET GROWTH (USD Billions)
(Research and Markets, 2025)
2024: ███████████████████████░░░░░░░░░░ $24.27B
2025: ████████████████████████████░░░░░ $28.46B ← Current
2026: ████████████████████████████████░ ~$33.3B (projected)
2029: ████████████████████████████████████████████████████ $53.2B (projected)
CAGR 2025–2029: 16.9% | CAGR 2024–2025: 17.3%
| Metric | Data Point | Year / Period |
|---|---|---|
| Digital health tracking apps market size | USD 28.46 billion | 2025 |
| Projected market size | USD 53.2 billion | 2029 |
| Market CAGR (2025–2029) | 16.9% | 2025–2029 |
| Market CAGR (historic 2024–2025) | 17.3% | 2024–2025 |
| AI prediction of IBD development (smart pill data) | 86% accuracy | University of California study |
| Patients comfortable using smart pills if prescribed | 78% | Drug Delivery Letters survey, 2022 |
| Elderly patients open to smart pill health monitoring | 73% | Separate elderly-focused study |
| Key bowel tracking features recommended by GIs | Stool type (BSFS), frequency, symptoms, diet | Clinical practice standard, 2026 |
| Top gut health tracking apps (iOS 2026) | Balloon, Plop, Bowelle, Cara Care, PoopLog | AppsHive / Balloon review, 2025–2026 |
| Gut health consumer awareness (U.S.) | 84% link gut health to daily wellbeing | YouGov / Sunsweet, Dec 2025 |
Sources: Research and Markets — Digital Health Tracking Apps Market Report, 2025; Media.Market.us — Digital Health Statistics (updated January 2026); University of California / IBD AI study (cited in Digital Health Statistics 2026); Drug Delivery Letters, 2022; AppsHive — Best Poop Tracker Apps of 2026; YouGov / Sunsweet Nutrition and Digestive Health Survey, December 2025
The digital gut health tracking market is expanding at a pace that reflects broader shifts in consumer health behavior — people are moving from reactive symptom management to proactive, data-driven digestive monitoring. The market for digital health tracking apps, valued at USD 28.46 billion in 2025 and projected to reach USD 53.2 billion by 2029, is being driven in significant part by the rise of chronic conditions like IBS and IBD, increased smartphone penetration, and growing demand for personalized health insights. Within this ecosystem, bowel movement tracking apps — tools that log stool type via the Bristol Scale, frequency, diet, hydration, stress, and symptoms — have moved from niche IBD management tools into mainstream wellness. Gastroenterologists routinely recommend structured bowel tracking before appointments because it dramatically improves diagnostic accuracy. Apps like Balloon, Plop, Bowelle, and Cara Care are designed specifically to generate doctor-ready reports that bring clinical-quality data into consultations that previously relied entirely on patient recall. The 86% accuracy rate of AI in predicting IBD development from smart pill data — reported by University of California researchers — signals where this field is heading: toward predictive, rather than purely reactive, gut health management.
Bowel Movement Health by Age & Gender 2026 | Who Is Most Affected?
Age and biological sex are among the strongest demographic predictors of bowel movement patterns, and the statistics tell a clear story about where the greatest clinical needs lie.
CONSTIPATION PREVALENCE BY AGE GROUP & GENDER (Estimated %)
(WGO 2025 | NHANES | Rome Foundation | PMC Research)
Women 18–35: ████████░░░░░░░░░░░░ ~14%
Women 36–65: ████████████░░░░░░░░ ~18%
Women 65+: ████████████████░░░░ ~26%
Men 18–35: ████░░░░░░░░░░░░░░░░ ~9%
Men 36–65: ██████░░░░░░░░░░░░░░ ~11%
Men 65+: ████████░░░░░░░░░░░░ ~16%
Older Adults (some regions): ████████████████████ up to 32%
Gender prevalence ratio (constipation): Women ~2× more than men
| Demographic | Condition | Prevalence / Finding | Key Factor |
|---|---|---|---|
| Women (global) | Any FGID | 49% meet criteria for ≥1 disorder | Hormonal influences, gut-brain axis |
| Men (global) | Any FGID | 36.6% meet criteria for ≥1 disorder | — |
| Women vs. men | Constipation | ~2× more prevalent in women | Hormonal, motility differences |
| Women (BSFS) | Stool type range | 90% report BSFS types 2–6 | Broader normal range in females |
| Men (BSFS) | Stool type range | 90% report BSFS types 3–5 | Narrower normal range in males |
| Older adults (65+) | Constipation | Up to 32% in some global regions | Polypharmacy, reduced mobility |
| IBS (global, Rome III) | IBS | Women ~12% vs. men ~9% | Female-to-male OR 1.8 (internet survey) |
| Younger adults (<35) | IBS | Higher IBS prevalence than older adults | Decreasing with age (internet data) |
| Hispanic adults (U.S.) | Abnormal bowel habits | Identified as key demographic risk factor | NHANES BSFS study data |
| Higher education / income | Normal bowel habits | Positively associated with regularity | NHANES data controlling for age |
Sources: Rome Foundation Global Study (Gastroenterology, 2021 — Sperber et al.); NHANES BSFS study (PubMed PMID 28762379); World Gastroenterology Organisation Guidelines, 2025; ISB / Cell Reports Medicine, 2024; PMC — Epidemiology and Burden of Chronic Constipation
The demographic data on bowel movement health reveals patterns that should directly shape how clinicians, public health professionals, and wellness brands communicate about gut health. The female predominance in constipation and most FGIDs is one of the most consistent findings in gastroenterological epidemiology — women are twice as likely as men to experience chronic constipation globally, and nearly half of all women worldwide meet criteria for at least one functional gastrointestinal disorder. This is not a minor clinical footnote. It represents a massive, systematically under-served health need. The NHANES data also highlights that normal bowel habits are positively associated with higher education, higher income, lower medication burden, and higher fiber intake — meaning constipation and irregular bowel patterns disproportionately affect socioeconomically disadvantaged populations, adding a health equity dimension to the conversation. For older adults, the compounding effects of polypharmacy (many common medications cause constipation), reduced physical activity, and dietary changes create a perfect storm for chronic constipation — with prevalence reaching up to 32% in some populations, making it the most common digestive complaint in that age group globally.
Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.